GP-Act III Acquisition Corp. $GPAT Shares Sold by MMCAP International Inc. SPC

MMCAP International Inc. SPC lowered its position in shares of GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report) by 38.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,275,000 shares of the company’s stock after selling 800,000 shares during the period. GP-Act III Acquisition comprises about 1.8% of MMCAP International Inc. SPC’s holdings, making the stock its 17th largest position. MMCAP International Inc. SPC’s holdings in GP-Act III Acquisition were worth $13,451,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Westchester Capital Management LLC grew its position in GP-Act III Acquisition by 27.6% in the first quarter. Westchester Capital Management LLC now owns 1,160,852 shares of the company’s stock worth $11,992,000 after buying an additional 250,852 shares during the last quarter. Wolverine Asset Management LLC boosted its holdings in GP-Act III Acquisition by 62.1% in the second quarter. Wolverine Asset Management LLC now owns 501,000 shares of the company’s stock worth $5,286,000 after purchasing an additional 191,950 shares in the last quarter. Mizuho Securities USA LLC bought a new position in shares of GP-Act III Acquisition in the 1st quarter valued at approximately $303,000. Finally, Wealthspring Capital LLC raised its holdings in GP-Act III Acquisition by 406.1% in the 2nd quarter. Wealthspring Capital LLC now owns 1,059,042 shares of the company’s stock worth $11,173,000 after acquiring an additional 849,783 shares during the period.

GP-Act III Acquisition Price Performance

GP-Act III Acquisition stock opened at $10.67 on Friday. The firm has a 50 day moving average price of $10.62 and a 200-day moving average price of $10.56. GP-Act III Acquisition Corp. has a twelve month low of $10.07 and a twelve month high of $10.71.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on GPAT shares. Wall Street Zen upgraded shares of GP-Act III Acquisition to a “hold” rating in a research note on Saturday, July 12th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, GP-Act III Acquisition presently has an average rating of “Sell”.

Get Our Latest Report on GPAT

About GP-Act III Acquisition

(Free Report)

GP-Act III Acquisition Corp. operates as a blank check company, which was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on November 23, 2020 and is headquartered in New York, NY.

Recommended Stories

Institutional Ownership by Quarter for GP-Act III Acquisition (NASDAQ:GPAT)

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.